Tony Michael Argenbright

Array ( [id] => 826997 [patent_doc_number] => 07402663 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-22 [patent_title] => 'Modified peptide' [patent_app_type] => utility [patent_app_number] => 10/469655 [patent_app_country] => US [patent_app_date] => 2002-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6427 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/402/07402663.pdf [firstpage_image] =>[orig_patent_app_number] => 10469655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7601678 [patent_doc_number] => 07385024 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-10 [patent_title] => 'Heterocarpine, a human GHRH-binding protein' [patent_app_type] => utility [patent_app_number] => 10/470112 [patent_app_country] => US [patent_app_date] => 2002-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 5128 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/385/07385024.pdf [firstpage_image] =>[orig_patent_app_number] => 10470112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7351126 [patent_doc_number] => 20040248782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Long lasting glucagon-like peptide2(glp-2)for the treatment of gastrointestinal diseases and disorders' [patent_app_type] => new [patent_app_number] => 10/203808 [patent_app_country] => US [patent_app_date] => 2002-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14512 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248782.pdf [firstpage_image] =>[orig_patent_app_number] => 10203808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7026437 [patent_doc_number] => 20050020493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Use of a polyfunctional active substance mixture as an antagonist against harmful substances contained in tobacco smoke' [patent_app_type] => utility [patent_app_number] => 10/485516 [patent_app_country] => US [patent_app_date] => 2002-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3213 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020493.pdf [firstpage_image] =>[orig_patent_app_number] => 10485516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6860632 [patent_doc_number] => 20030091640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Enhanced oral and transcompartmental delivery of therapeutic or diagnostic agents' [patent_app_type] => new [patent_app_number] => 10/072657 [patent_app_country] => US [patent_app_date] => 2002-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 28849 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20030091640.pdf [firstpage_image] =>[orig_patent_app_number] => 10072657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1107919 [patent_doc_number] => 06809079 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-10-26 [patent_title] => 'Compositions and methods for treating female sexual arousal disorder using hydrophobic-calcitonin gene related peptide' [patent_app_type] => B2 [patent_app_number] => 10/041244 [patent_app_country] => US [patent_app_date] => 2002-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5556 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/809/06809079.pdf [firstpage_image] =>[orig_patent_app_number] => 10041244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 522230 [patent_doc_number] => 07186693 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-06 [patent_title] => 'Metalloproteinase inhibitors for wound healing' [patent_app_type] => utility [patent_app_number] => 10/032376 [patent_app_country] => US [patent_app_date] => 2001-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 17613 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/186/07186693.pdf [firstpage_image] =>[orig_patent_app_number] => 10032376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6112518 [patent_doc_number] => 20020173452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'Cytostatic-glycoconjugates having specifically cleavable linking units' [patent_app_type] => new [patent_app_number] => 10/026237 [patent_app_country] => US [patent_app_date] => 2001-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12392 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20020173452.pdf [firstpage_image] =>[orig_patent_app_number] => 10026237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 542934 [patent_doc_number] => 07169755 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-30 [patent_title] => 'Solution for removing cataracts via liquefracture' [patent_app_type] => utility [patent_app_number] => 10/433166 [patent_app_country] => US [patent_app_date] => 2001-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3871 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/169/07169755.pdf [firstpage_image] =>[orig_patent_app_number] => 10433166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1141939 [patent_doc_number] => 06777386 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-17 [patent_title] => 'Sustained peptide-release formulation' [patent_app_type] => B2 [patent_app_number] => 09/991714 [patent_app_country] => US [patent_app_date] => 2001-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 4479 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/777/06777386.pdf [firstpage_image] =>[orig_patent_app_number] => 09991714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6445152 [patent_doc_number] => 20020177125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-28 [patent_title] => 'Human rhinovirus assays, and compositions therefrom' [patent_app_type] => new [patent_app_number] => 09/991003 [patent_app_country] => US [patent_app_date] => 2001-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 34607 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20020177125.pdf [firstpage_image] =>[orig_patent_app_number] => 09991003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6177710 [patent_doc_number] => 20020156010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Method of treating obesity in adult patients exhibiting primary insulin hypersecretion' [patent_app_type] => new [patent_app_number] => 10/006738 [patent_app_country] => US [patent_app_date] => 2001-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10548 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20020156010.pdf [firstpage_image] =>[orig_patent_app_number] => 10006738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 961130 [patent_doc_number] => 06951843 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-04 [patent_title] => 'Peptide derivatives and their pharmaceutically acceptable salts, thereof, processes for preparation of both and use thereof' [patent_app_type] => utility [patent_app_number] => 10/168540 [patent_app_country] => US [patent_app_date] => 2001-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15225 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/951/06951843.pdf [firstpage_image] =>[orig_patent_app_number] => 10168540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1065680 [patent_doc_number] => 06846806 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-25 [patent_title] => 'Peptide inhibitors of Hepatitis C virus NS3 protein' [patent_app_type] => utility [patent_app_number] => 10/039317 [patent_app_country] => US [patent_app_date] => 2001-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36886 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/846/06846806.pdf [firstpage_image] =>[orig_patent_app_number] => 10039317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1138755 [patent_doc_number] => 06780840 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-24 [patent_title] => 'Method for making a light energized tissue adhesive' [patent_app_type] => B1 [patent_app_number] => 09/973263 [patent_app_country] => US [patent_app_date] => 2001-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5089 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/780/06780840.pdf [firstpage_image] =>[orig_patent_app_number] => 09973263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1144215 [patent_doc_number] => 06773699 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-10 [patent_title] => 'Light energized tissue adhesive conformal patch' [patent_app_type] => B1 [patent_app_number] => 09/973385 [patent_app_country] => US [patent_app_date] => 2001-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5090 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/773/06773699.pdf [firstpage_image] =>[orig_patent_app_number] => 09973385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1034220 [patent_doc_number] => 06875427 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-04-05 [patent_title] => 'Light energized tissue adhesive' [patent_app_type] => utility [patent_app_number] => 09/973332 [patent_app_country] => US [patent_app_date] => 2001-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5093 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/875/06875427.pdf [firstpage_image] =>[orig_patent_app_number] => 09973332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7470978 [patent_doc_number] => 20040096898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Caloxins' [patent_app_type] => new [patent_app_number] => 10/363701 [patent_app_country] => US [patent_app_date] => 2003-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8564 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20040096898.pdf [firstpage_image] =>[orig_patent_app_number] => 10363701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6905195 [patent_doc_number] => 20050100590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Liposomes encapsulating anticancer drugs and use thereof in the treatment of malignant tumours' [patent_app_type] => utility [patent_app_number] => 10/398627 [patent_app_country] => US [patent_app_date] => 2001-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6984 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20050100590.pdf [firstpage_image] =>[orig_patent_app_number] => 10398627 [rel_patent_id] =>[rel_patent_doc_number] =>)